Jazz Pharmaceuticals plc 4

Director Patrick G. Enright received an award of 1,605 restricted stock units of Jazz Pharmaceuticals plc on August 5, 2026.

On August 5, 2026, non-employee director Patrick G. Enright received an award of 1,605 restricted stock units (RSUs) of Jazz Pharmaceuticals plc, with each unit representing a contingent right to receive one ordinary share upon vesting. The grant was made under the issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan and is scheduled to vest in full on July 23, 2027, subject to continued service and certain additional conditions. Following this equity award, Enright's direct beneficial ownership increased to 22,984 ordinary shares. No open-market purchases or sales occurred in this filing; the activity reflects routine director equity compensation.

Filing Facts

CIK

1232524

Ticker

JAZZ

Form

4

Source Type

fda

Accession

0001253886-26-000008

Alert Tier

5